These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17455929)

  • 61. Recent advances in positive allosteric modulators of the AMPA receptor.
    Morrow JA; Maclean JK; Jamieson C
    Curr Opin Drug Discov Devel; 2006 Sep; 9(5):571-9. PubMed ID: 17002217
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tuning activation of the AMPA-sensitive GluR2 ion channel by genetic adjustment of agonist-induced conformational changes.
    Armstrong N; Mayer M; Gouaux E
    Proc Natl Acad Sci U S A; 2003 May; 100(10):5736-41. PubMed ID: 12730367
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of the agonist binding site of homomeric, heteromeric, and chimeric GluR1(o) and GluR3(o) AMPA receptors.
    Banke TG; Schousboe A; Pickering DS
    J Neurosci Res; 1997 Jul; 49(2):176-85. PubMed ID: 9272640
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Biostructural and pharmacological studies of bicyclic analogues of the 3-isoxazolol glutamate receptor agonist ibotenic acid.
    Frydenvang K; Pickering DS; Greenwood JR; Krogsgaard-Larsen N; Brehm L; Nielsen B; Vogensen SB; Hald H; Kastrup JS; Krogsgaard-Larsen P; Clausen RP
    J Med Chem; 2010 Dec; 53(23):8354-61. PubMed ID: 21067182
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Disruption of agonist and ligand activity in an AMPA glutamate receptor splice-variable domain deletion mutant.
    Johnson WD; Parandaman V; Onaivi ES; Taylor RE; Akinshola BE
    Brain Res; 2008 Jul; 1222():18-30. PubMed ID: 18585685
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacological characterization, localization, and regulation of ionotropic glutamate receptors in skate horizontal cells.
    Kreitzer MA; Birnbaum AD; Qian H; Malchow RP
    Vis Neurosci; 2009; 26(4):375-87. PubMed ID: 19678977
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Subunit-selective palmitoylation regulates the intracellular trafficking of AMPA receptor.
    Yang G; Xiong W; Kojic L; Cynader MS
    Eur J Neurosci; 2009 Jul; 30(1):35-46. PubMed ID: 19508696
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Discovery of functionally selective 7,8,9,10-tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazines as GABA A receptor agonists at the alpha3 subunit.
    Russell MG; Carling RW; Atack JR; Bromidge FA; Cook SM; Hunt P; Isted C; Lucas M; McKernan RM; Mitchinson A; Moore KW; Narquizian R; Macaulay AJ; Thomas D; Thompson SA; Wafford KA; Castro JL
    J Med Chem; 2005 Mar; 48(5):1367-83. PubMed ID: 15743180
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Design, synthesis, and pharmacology of novel 7-substituted 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides as positive allosteric modulators of AMPA receptors.
    Francotte P; Tullio Pd; Goffin E; Dintilhac G; Graindorge E; Fraikin P; Lestage P; Danober L; Thomas JY; Caignard DH; Pirotte B
    J Med Chem; 2007 Jun; 50(13):3153-7. PubMed ID: 17552506
    [TBL] [Abstract][Full Text] [Related]  

  • 70. 5-Substituted imidazole-4-acetic acid analogues: synthesis, modeling, and pharmacological characterization of a series of novel gamma-aminobutyric acid(C) receptor agonists.
    Madsen C; Jensen AA; Liljefors T; Kristiansen U; Nielsen B; Hansen CP; Larsen M; Ebert B; Bang-Andersen B; Krogsgaard-Larsen P; Frølund B
    J Med Chem; 2007 Aug; 50(17):4147-61. PubMed ID: 17655213
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Picosecond dynamics of the glutamate receptor in response to agonist-induced vibrational excitation.
    Kubo M; Shiomitsu E; Odai K; Sugimoto T; Suzuki H; Ito E
    Proteins; 2004 Feb; 54(2):231-6. PubMed ID: 14696185
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Structure of the S1S2 glutamate binding domain of GLuR3.
    Ahmed AH; Wang Q; Sondermann H; Oswald RE
    Proteins; 2009 May; 75(3):628-37. PubMed ID: 19003990
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Positive allosteric modulators of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor.
    Grove SJ; Jamieson C; Maclean JK; Morrow JA; Rankovic Z
    J Med Chem; 2010 Oct; 53(20):7271-9. PubMed ID: 20839777
    [No Abstract]   [Full Text] [Related]  

  • 74. Purification and crystallization of a non-GluR2 AMPA-receptor ligand-binding domain: a case of cryo-incompatibility addressed by room-temperature data collection.
    Gill A; Madden DR
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Sep; 64(Pt 9):831-5. PubMed ID: 18765917
    [TBL] [Abstract][Full Text] [Related]  

  • 75. AMPA receptor activation reduces epileptiform activity in the rat neocortex.
    Addae JI; Ali N; Youssef FF; Stone TW
    Brain Res; 2007 Jul; 1158():151-7. PubMed ID: 17543292
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Characterization of the 1H-cyclopentapyrimidine-2,4(1H,3H)-dione derivative (S)-CPW399 as a novel, potent, and subtype-selective AMPA receptor full agonist with partial desensitization properties.
    Campiani G; Morelli E; Nacci V; Fattorusso C; Ramunno A; Novellino E; Greenwood J; Liljefors T; Griffiths R; Sinclair C; Reavy H; Kristensen AS; Pickering DS; Schousboe A; Cagnotto A; Fumagalli E; Mennini T
    J Med Chem; 2001 Dec; 44(26):4501-4. PubMed ID: 11741469
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mapping the melatonin receptor. 7. Subtype selective ligands based on beta-substituted N-acyl-5-methoxytryptamines and beta-substituted N-acyl-5-methoxy-1-methyltryptamines.
    Tsotinis A; Vlachou M; Papahatjis DP; Calogeropoulou T; Nikas SP; Garratt PJ; Piccio V; Vonhoff S; Davidson K; Teh MT; Sugden D
    J Med Chem; 2006 Jun; 49(12):3509-19. PubMed ID: 16759094
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neurosteroid analogues. 14. Alternative ring system scaffolds: GABA modulatory and anesthetic actions of cyclopenta[b]phenanthrenes and cyclopenta[b]anthracenes.
    Scaglione JB; Jastrzebska I; Krishnan K; Li P; Akk G; Manion BD; Benz A; Taylor A; Rath NP; Evers AS; Zorumski CF; Mennerick S; Covey DF
    J Med Chem; 2008 Mar; 51(5):1309-18. PubMed ID: 18275132
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synthesis and Pharmacology of Mono-, Di-, and Trialkyl-Substituted 7-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides Combined with X-ray Structure Analysis to Understand the Unexpected Structure-Activity Relationship at AMPA Receptors.
    Larsen AP; Francotte P; Frydenvang K; Tapken D; Goffin E; Fraikin P; Caignard DH; Lestage P; Danober L; Pirotte B; Kastrup JS
    ACS Chem Neurosci; 2016 Mar; 7(3):378-90. PubMed ID: 26771108
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists.
    Nelson DW; Gregg RJ; Kort ME; Perez-Medrano A; Voight EA; Wang Y; Grayson G; Namovic MT; Donnelly-Roberts DL; Niforatos W; Honore P; Jarvis MF; Faltynek CR; Carroll WA
    J Med Chem; 2006 Jun; 49(12):3659-66. PubMed ID: 16759108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.